Synlogic inc

Author: romb

August undefined, 2024

WebApr 12, 2024 · 3 Wall Street analysts have issued 12 month price objectives for Synlogic's shares. Their SYBX share price forecasts range from $5.50 to $8.00. On average, they … WebApr 11, 2024 · • Cellevolve Bio Inc. has no parent corporation. No publicly traded corporation owns 10% or more of Cellevolve Bio Inc.’s stock. • Curae Pharma360 Inc.’s parent is Medicines360. company Medicines360 owns 100% of Curiae Pharma360 Inc.’s stock. Case: 23-10362 Document: 75-2 Page: 3 Date Filed: 04/11/2024

News Releases Investor Relations Synlogic

WebAug 11, 2024 · Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 4.35% and 49.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what … WebMar 29, 2024 · CAMBRIDGE, Mass., March 29, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, … community colleges near omaha

News Releases Investor Relations Synlogic

WebSep 1, 2024 · A look at the shareholders of Synlogic, Inc. (NASDAQ:SYBX) can tell us which group is most powerful. Generally speaking, as a company grows, institutions will increase their ownership. WebSynlogic的新闻 Synlogic(SYBX.US)SYNB1934获美FDA罕见儿科疾病认定盘前涨近10%. 智通财经APP获悉，美国食品和药物管理局(FDA)授予Synlogic(SYBX.US)的SYNB1934治疗苯 … WebNov 10, 2024 · Synlogic, Inc. Condensed Consolidated Balance Sheets (unaudited) (in thousands, except share data) September 30, 2024. December 31, 2024. Assets. Cash, … community colleges near new bern nc

Synlogic Inc (SYBX) News Headlines - uk.advfn.com

Synlogic Announces Positive Top-Line Phase 2 Data for

WebApr 12, 2024 · Synlogic Inc’s trailing 12-month revenue is $1.2 million with a % profit margin. Year-over-year quarterly sales growth most recently was -83.3%. Analysts expect adjusted … WebMar 29, 2024 · As of December 31, 2024, Synlogic had cash, cash equivalents, and short-term marketable securities of $77.6 million. Revenue was $0.1 million for the three … community colleges near omaha nebraskaWebApr 12, 2024 · The Synlogic Inc stock price gained 15.26% on the last trading day (Thursday, 6th Apr 2024), rising from $0.501 to $0.577. During the last trading day the stock … duke university neurocritical care fellowship

"WebSynlogic, Inc. engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, ... " - Synlogic inc

Synlogic inc

WebSep 7, 2024 · Synlogic’s initial pipeline includes Synthetic Biotic medicines for the treatment of rare genetic diseases, such as Urea Cycle Disorder (UCD) and Phenylketonuria (PKU). In addition, the company is leveraging the broad potential of its platform to create Synthetic Biotic medicines for the treatment of other diseases, such as liver disease, inflammatory … WebFunding. Synlogic has raised a total of $321.4M in funding over 8 rounds. Their latest funding was raised on Sep 22, 2024 from a Post-IPO Equity round. Synlogic is registered …

Did you know?

WebApr 11, 2024 · Having served at the director level at multiple pharmaceutical companies, she is now President and CEO of Synlogic Inc., a clinical-stage synthetic biology company that is developing an entirely ... WebAug 11, 2024 · Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to synthetic biology, today ...

WebMar 20, 2024 · Company Overview. Founded in 2014 by MIT professors Jim Collins and Tim Lu, Synlogic combines synthetic biology, a form of precision biological engineering, with … WebApr 12, 2024 · Estadísticas y tendencias del mercado mundial Fenilcetonuria 2024-2033: Synlogic Inc., BioMarin Pharmaceuticals Inc., Homology Medicines Inc., Rubius Therapeutics Inc. 12 abril, 2024 por Robert Disuza

WebMar 29, 2024 · CAMBRIDGE, Mass., March 29, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, … WebSynlogic, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of synthetic biology therapeutics for the treatment of rare, …

WebJan 19, 2024 · Synlogic Inc (SYBX) Synlogic Inc (SYBX) News; SYBX. Synlogic Inc 0.68435. 0.00735 (1.09%) Upgrade to Real-Time Share Price; Chart; Level 2; News; Trades; Options New; Financials; Historical; Buy. Sell. Share Name Share Symbol Market Type; Synlogic Inc: NASDAQ:SYBX: NASDAQ: Common Stock Price Change

community colleges near northridgeWebOct 18, 2024 · Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3. October 18, 2024 06:59 ET Source: Synlogic, Inc. Positive results include clinically ... duke university nearest airportWebNov 18, 2024 · Antoine 'Tony' Awad is a Chief Operating Officer at SYNLOGIC, INC. and is based in Greater Boston Area. He has experience at MERRIMACK PHARMACEUTICALS … community colleges near oswego ilWebMar 7, 2024 · News Releases. Synlogic Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates. Synlogic Receives Positive Opinion on Orphan … duke university ncaa tournamentWebPIPELINE. Synlogic’s pipeline includes its lead program in phenylketonuria (PKU), which completed a Phase 2 study with plans to initiate a pivotal, Phase 3 study, and additional … duke university neurobiology phdWebFor the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing … duke university nephrology fellowshipWebSynlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic and immunological diseases in the … community colleges near oswego ny